Phase I trial of lebrikizumab in volunteers.
Phase of Trial: Phase I
Latest Information Update: 06 Sep 2011
At a glance
- Drugs Lebrikizumab (Primary)
- Indications Asthma
- Focus Adverse reactions
- Sponsors Tanox
- 06 Sep 2011 Status changed from active, no longer recruiting to unconfirmed (it is not clear if Tanox completed this trial as the company was later acquired by Genentech).
- 01 Nov 2006 New trial record.